Abstract: Disclosed are a bisdiazabicyclo compound for treating and/or preventing hepatitis virus-related diseases or disorders, a method for treating and/or preventing hepatitis virus-related diseases or disorders by using the bisdiazabicyclo compound, and a use of the bisdiazabicyclo compound in the preparation of a drug for treating and/or preventing hepatitis virus-related diseases or disorders, and/or eliminating or mitigating hepatitis virus-related diseases or disorders.
Type:
Grant
Filed:
November 20, 2018
Date of Patent:
April 12, 2022
Assignees:
JIANGSU ASCENTAGE BIOMED DEVELOPMENT INC., HEALTHQUEST PHARMA INC.
Inventors:
Yifan Zhai, Xiaoyong Zhang, Jinlin Hou, Dajun Yang
Abstract: Disclosed herein are certain indoloquinolone compounds, methods of preparation thereof, pharmaceutical compositions thereof, and uses thereof, such as their uses as ALK inhibitors.
Type:
Grant
Filed:
February 27, 2014
Date of Patent:
October 10, 2017
Assignee:
Jiangsu Ascentage Biomed Development Inc.
Inventors:
Jianyong Chen, Yunlong Zhou, Shaomeng Wang, Ming Guo, Dajun Yang, Lingling Jiao, Yu Jing, Xu Qian, Liu Liu, Longchuan Bai, Chao-Yie Yang, Donna McEachern
Abstract: Disclosed herein are certain indoloquinolone compounds, methods of preparation thereof, pharmaceutical compositions thereof, and uses thereof, such as their uses as ALK inhibitors
Type:
Application
Filed:
February 27, 2014
Publication date:
March 9, 2017
Applicant:
Jiangsu Ascentage Biomed Development Inc.
Inventors:
Jianyong CHEN, Yunlong ZHOU, Shaomeng WANG, Ming GUO, Dajun YANG, Lingling JIAO, Yu JING, Xu QIAN, Liu LIU, Longchuan BAI, Chao-Yie YANG, Donna MCEACHERN